Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Caribou To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Caribou between July 14, 2023 and July 16, 2024 and would like to discuss…
Category: Uncategorized
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cardlytics between March 14, 2024 and August 7, 2024 and would like to…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AstraZenecaTo Contact Him Directly To Discuss Their Options If you purchased or acquired securities in AstraZeneca between between February 23, 2022 and December 17, 2024 and…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Micron To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Micron between September 23, 2023 and December 18, 2024 and would like to…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BioAge To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BioAge between September 26, 2024 and January 7, 2025 and would like to…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Applied Therapeutics January 3, 2024 and December 2, 2024 and…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ESSA Pharma To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in ESSA Pharma between December 12, 2023 and October 31, 2024 and would…
Bahri surpasses SAR 2 billion annual net profit for the first time. Historic 2024 net profit of SAR 2.17 billion (+34% YoY) and record revenue of SAR 9.48 billion, (+8% YoY). Q4 2024 net profit of SAR 474 million (+18% YoY), reflecting sustained revenue growth and enhanced cost…
SINGAPUR, 2. Februar 2025 /PRNewswire/ — Hotel101 Global Pte. Ltd („Hotel101″ oder „HBNB”), einer auf schnelles globales Wachstum ausgerichteten, vermögensleichten Prop-Tech-Plattform für das Gastgewerbe, und JVSPAC Acquisition Corp. (NASDAQ: JVSA) („JVSPAC”), eine auf Akquisitionen…
WASHINGTON, Feb. 1, 2025 /PRNewswire/ — Trade measures against unfairly traded Canadian lumber imports are strengthening domestic supply lines by maximizing long-term lumber output by U.S. workers to build U.S. homes. Since 2016, U.S. mills have added eight billion board feet of…